1. AB0822 Therapeutic Response in Adalimumab-Treated Patients with Psoriatic Arthritis in Relation to Weight. (9th June 2015) Authors: Mease, P.; Gladman, D.D.; Ritchlin, C.T.; Warren, R.B.; Rubant, S.; Li, Y.; Dorr, A.P.; Anderson, J.K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate‐to‐severe plaque psoriasis: a randomized controlled trial. (17th August 2021) Authors: Thaçi, D.; Eyerich, K.; Pinter, A.; Sebastian, M.; Unnebrink, K.; Rubant, S.; Williams, D. A.; Weisenseel, P. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate‐to‐severe plaque psoriasis: a randomized controlled trial. (1st January 2022) Authors: Thaçi, D.; Eyerich, K.; Pinter, A.; Sebastian, M.; Unnebrink, K.; Rubant, S.; Williams, D. A.; Weisenseel, P. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up. (1st December 2021) Authors: Papp, K.A.; Lebwohl, M.G.; Puig, L.; Ohtsuki, M.; Beissert, S.; Zeng, J.; Rubant, S.; Sinvhal, R.; Zhao, Y.; Soliman, A.M.; Alperovich, G.; Leonardi, C. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up. (21st September 2021) Authors: Papp, K.A.; Lebwohl, M.G.; Puig, L.; Ohtsuki, M.; Beissert, S.; Zeng, J.; Rubant, S.; Sinvhal, R.; Zhao, Y.; Soliman, A.M.; Alperovich, G.; Leonardi, C. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial. (12th July 2021) Authors: Thaçi, D.; Soliman, A.M.; Eyerich, K.; Pinter, A.; Sebastian, M.; Unnebrink, K.; Rubant, S.; Williams, D.A.; Weisenseel, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: 1686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study. (1st December 2019) Authors: Thaçi, D.; Papp, K.; Marcoux, D.; Weibel, L.; Pinter, A.; Ghislain, P.‐D.; Landells, I.; Hoeger, P.H.; Unnebrink, K.; Seyger, M.M.B.; Williams, D.A.; Rubant, S.; Philipp, S. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study. (25th July 2019) Authors: Thaçi, D.; Papp, K.; Marcoux, D.; Weibel, L.; Pinter, A.; Ghislain, P.‐D.; Landells, I.; Hoeger, P.H.; Unnebrink, K.; Seyger, M.M.B.; Williams, D.A.; Rubant, S.; Philipp, S. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗